Dieter Koch - STADA Arzneimittel Insider

STDAF -- USA Stock  

USD 96.10  0.00  0.00%

  Executive
Mr. Dieter Koch was Member of the Supervisory Board at STADA Arzneimittel AG from 1983 to August 26 2016. He served as Member of the Human Resources Committee at the Company. From 1966 to 1990 he was Managing Director of SonnenApotheke in Germany and from 1975 to 1990 served as Chairman of the Examination Board for Pharmacy Assistants. He was previously the Deputy Chairman of the Employers Association of German Pharmacies. From 1970 to 1983 he was a Member of the Advisory Board at STADA Arzneimittel AG. He studied pharmacy in Kiel Germany.
Age: 78  Executive Since 1983      
49 6101 603 0  http://www.stada.de

Management Efficiency

The company has return on total asset (ROA) of 6.33 % which means that it generated profit of $6.33 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 14.86 % meaning that it generated $14.86 on every $100 dollars invested by stockholders.
The company has accumulated 1.65 B in total debt with debt to equity ratio (D/E) of 123.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. STADA Arzneimittel Aktiengesellschaft has Current Ratio of 1.22 suggesting that it may have difficulties to pay its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives

EXECUTIVE Since

Cameron BattleyAurora Cannabis
2018
Karina CalzadillaAllergan plc
2017
Alex KellyAllergan plc
2015
Neil BelotAurora Cannabis
2017
David StarkTeva Pharmaceutical Industries
2016
Tokumasa TakedaTakeda Pharmaceutical Company L
2016
Andrew PlumpTakeda Pharmaceutical Company L
2015
Darryl VleemingAurora Cannabis
2017
Allan CleirenAurora Cannabis
2017
Robert BaileyAllergan plc
2016
James DAreccaAllergan plc
2013
Bill MacdonaldAurora Cannabis
N/A
Bradley JosephPerrigo Company plc
2017
Nilda RiveraAurora Cannabis
2017
Karen LingAllergan plc
2016
Daniel GallagherMylan N V
2017
NicholsonAllergan plc
2015
Dennis ZelenyMylan N V
2017
Arthur ShannonPerrigo Company plc
N/A
Timothy WrightTeva Pharmaceutical Industries
2015

Entity Summary

STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of pharmaceutical products for the health care and pharmaceutical markets worldwide. STADA Arzneimittel Aktiengesellschaft is a subsidiary of Nidda Healthcare Holding GmbH. STADA Arzneimittel operates under Drug Manufacturers - Specialty Generic classification in USA and traded on OTC Market. It employs 10232 people.STADA Arzneimittel Aktiengesellschaft (STDAF) is traded on OTC Market in USA. It is located in Stadastrasse 2-18 and employs 10,232 people.

STADA Arzneimittel Leadership Team

Carl Oetker, Member of the Supervisory Board
JanNicolas Garbe, Member of the Supervisory Board
Dieter Koch, Member of the Supervisory Board
Eckhard Brueggemann, Member of the Supervisory Board
Mark Keatley, CFO, Member of the Executive Board
Ralph Grobecker, Managing Director of OTC segment
Martin Abend, Chairman of the Supervisory Board
Matthias Wiedenfels, Chief Bus. Devel. and Central Services Officer and Member of Executive Board
Arnold Hertzsch, Member of the Supervisory Board
Halil Duru, Member of the Supervisory Board
Tina Mueller, Member of the Supervisory Board
Engelbert Willink, Chairman of the Executive Board, CEO
Barthold Piening, Chief Technical Operations Officer, Member of the Executive Board
Steffen Wagner, Member of the Management Board, Head of Europe
Helmut Kraft, CFO and Member of Executive Board
Ute Pantke, Member of the Supervisory Board
Carsten Cron, Member of the Management Board, Head Emerging Markets
Frank Seiler, IR Contact Officer
Hartmut Retzlaff, Chairman of The Executive Board
Bernhard Duettmann, CFO
Miguel Pagan, Member of the Executive Board
Claudio Albrecht, Chairman of the Executive Board, CEO
Michael Siefke, Member of the Supervisory Board
Leslie Iltgen, Vice President Investor Relations
Eric Cornut, Member of the Supervisory Board
Peter Goldschmidt, Chairman of the Executive Board
Robert Knerr, Member of the Management Board, Head of Business Development
Jens Steegers, Member of the Supervisory Board
Birgit Kudlek, Member of the Supervisory Board
Guenter Au, Chairman of the Supervisory Board
Constantin Meyer, Member of the Supervisory Board
Rolf Hoffmann, Member of the Supervisory Board
Markus Metzger, Director of Investor Relations
Benjamin Kunstler, Member of the Supervisory Board
Gunnar Riemann, Member of the Supervisory Board
Bruno Schick, Member of the Supervisory Board

Stock Performance Indicators

Did you try this?

Run Portfolio Backtesting Now

   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Portfolio Backtesting
Currently Active Assets on Macroaxis
GM   
Purchased over 70 shares of
a day ago
Traded for 35.02
CRM   
Purchased a lot of shares of
a day ago
Traded for 154.92
MSFT   
Purchased over 20 shares of
a day ago
Traded for 112.14
F   
Purchased over 300 shares of
a day ago
Traded for 9.55
S   
Purchased over 400 shares of
a day ago
Traded for 6.33
Also please take a look at World Market Map. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Search macroaxis.com